Revenue: As of FY2025 Q1, the actual value is USD 12.26 M.EPS: As of FY2025 Q1, the actual value is USD -0.04.<h3>Segment Revenue</h3><ul><li>Total Revenue: For the three months ended March 31, 2025, total revenue was $12,262, an increase of 1.1% compared to $12,124 for the same period in 2024.</li><li>Product Revenue: Product revenue increased by 3.2% to $12,187 in 2025 from $11,813 in 2024.</li><li>Service Revenue: Service revenue decreased by 75.9% to $75 in 2025 from $311 in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Profit: Gross profit for the three months ended March 31, 2025 was $6,230, a decrease of 9.9% compared to $6,911 for the same period in 2024.</li><li>Gross Margin: Gross margin decreased to 50.8% in 2025 from 57.0% in 2024.</li><li>Operating Loss: Operating loss for the three months ended March 31, 2025 was -$5,348, an improvement from -$8,369 in 2024.</li><li>Net Loss: Net loss for the three months ended March 31, 2025 was -$6,212, compared to -$9,634 in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: Net cash used in operating activities for the three months ended March 31, 2025 was -$2,768, compared to -$7,179 in 2024.</li><li>Net Cash Used in Investing Activities: Net cash used in investing activities for the three months ended March 31, 2025 was -$493, compared to -$2,033 in 2024.</li><li>Net Cash Used in Financing Activities: There was no net cash used in financing activities for the three months ended March 31, 2025, compared to -$98 in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The Company is focused on reducing negative cash flows from operations and expects a reduction in overall selling, general, and administrative expenses in 2025 due to improvements in operating efficiency and cost savings from a more efficient e-commerce platform.</li><li>Non-Core Business: The Company is expanding its product line beyond hemp-based products and is involved in a collaboration with DeFloria, Inc. for botanical drug development.</li><li>Priority: The Company is committed to innovation and expanding its wellness offerings beyond CBD to include a broader range of botanical-based wellness solutions, including minor cannabinoids.</li></ul>

Charlotte's Web Holdings, Inc. | 10-Q: FY2025 Q1 Revenue: USD 12.26 M